83 /100
CRITICAL RISK
Score updated May 16, 2026

STI — Solidion Technology, Inc. Dilution Risk Tracker

Track STI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track STI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
80
⚠️ Warrant Exposure
70
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
52%
💰 Capital Raise 75%
• Critical: only 0.1 months cash remaining
• Active shelf registration ($13M, 29% of market cap)
📜 Warrant Exercise 40%
• Significant warrants: 29% of shares outstanding
• Elevated warrant risk score (70/100)
📉 Score Deterioration 15%
• Score already CRITICAL (83/100) — events likely imminent
🔔 Track STI — Get forecast alerts →

💹 Market Data

Market Cap$42.99M
Shares Outstanding7.75M
Float2.47M
Cash$204.7K
Debt$2.65M
Short InterestN/A

🏛 Institutional Holdings

3 institutional holders · 793.7K shares
#1 NEW YORK STATE COMMON RETIREMENT FUND 652.4K shares
#2 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 139.8K shares
#3 ROYAL BANK OF CANADA 1.5K shares

📉 Short Interest

Short Interest243.6K
Days to Cover2.0
% of Float9.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
S-1 SHELF Feb 12, 2026
8-K 8K EVENT Feb 12, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track STI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking STI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for STI
📊 STI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 STI Signal Convergence & Dark Pool Activity — StonkWhisper 📄 STI Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.